Jushi’s stock edged up modestly by 0.8% following a quarter marked by modest revenue growth and expanding margins but tempered by ongoing pricing pressure and increased promotions in retail.

• Revenue rose 4% year-over-year to $66.4 million, driven by retail expansion in Ohio and Virginia and wholesale growth in Massachusetts and Ohio.
• Wholesale revenue increased 22.2%, supported by additional dispensary customers (+32) and new SKUs (+45% YoY).
• Gross margin improved to 45% from 40.4% despite pricing pressure and promotional expenses in retail.
• Adjusted EBITDA rose to $11.4 million (17.2% margin), benefiting from operational execution but excluding $2.8 million of nonrecurring credits from prior year.
• Federal rescheduling of medical cannabis to Schedule III is a significant positive development with potential tax benefits going forward.